Gimme Care review

What it is

Gimme Care is a telehealth service selling compounded semaglutide and tirzepatide, including microdose options, alongside an anti-aging line covering NAD⁺ injection, sermorelin injection, glutathione injection, MIC+B12, cyanocobalamin and an NAD⁺-plus-glutathione bundle. It is LegitScript verified, states availability in all 50 states plus the District of Columbia, and advertises no membership fees, free shipping from licensed US facilities, and the same price at every dose. Five states — Kansas, Louisiana, Mississippi, New Mexico and West Virginia — require a video or audio visit rather than an asynchronous online intake.

How it works

An online intake reviewed by a licensed provider, or a live video or audio visit in the five states that require one, then shipping from licensed US facilities. Being explicit about which states need a synchronous visit is a small thing that most competitors skip, and it removes a surprise at the point of enrolment. The all-in pricing structure is the other structural strength: the platform states plainly that the price covers medication, physician care, support, shipping and all supplies with no hidden fees or membership costs, so there is no second bill to discover. What is missing is sourcing and clinical depth. No compounding pharmacy is named. No individual clinician or medical director is disclosed. No lab work appears anywhere in the described pathway, which matters before a growth-hormone-axis peptide — an IGF-1 baseline is the obvious thing to want and you would need to arrange it yourself. And nothing on the site distinguishes between the six anti-aging products in evidence terms; they are presented as one menu.

Pricing transparency

The strongest part of the proposition, and a genuine correction to the provider's record, which carried no peptide pricing whatsoever. Each anti-aging injection is priced on its own line with both a month-to-month and a three-month figure: sermorelin injection at $189 or $179, NAD⁺ injection at $129 or $99, glutathione injection at $99 or $63, MIC+B12 at $129 or $99, and cyanocobalamin at $84 or $66, with an NAD⁺-plus-glutathione bundle offered separately. On the weight-loss side, compounded semaglutide is $160 month-to-month or $130 on a three-month plan and tirzepatide $199 or $163. The three-month figures are billed as a block, so the lower rate is a commitment rather than a discount you can walk away from mid-cycle; its cancellation terms state no membership fee but do not set out a refund policy, so establish how you stop the charge before starting it. The same-price-at-every-dose statement is published as a product-page benefit, which makes a full course budgetable in a way dose-scaled pricing is not.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Gimme Care states this on its own pages — its disclaimer reads that compounded products are not approved nor evaluated for safety, efficacy or quality by the FDA, and that medication is provided only if a licensed provider deems it appropriate — which is the right framing and more than several competitors bother with. It does not name the compounding pharmacy, and compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are. On the evidence, the three products this board cares about sit on three different footings and the site treats them as one category. Sermorelin acts on the growth-hormone axis, a real and well-described mechanism whose long-term human outcome data stays thin, with no controlled trial behind the body-composition or anti-aging claims. Injected NAD⁺ has no controlled human outcome trials at all; the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly, and the forms with human data are oral NR and NMN, which raise a blood level rather than demonstrate a benefit. Injectable glutathione has essentially no controlled human outcome evidence for the antioxidant and skin claims attached to it. Individual results vary.

Pros and watch-outs

The evidence behind what Gimme Care prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

How Gimme Care compares

A few alternatives worth a look, depending on what you’re optimizing for.

• CoreAge Rx

  Injected or intranasal NAD⁺ at a published price across 50 states

  See CoreAge Rx →
• LHLuvo Health

  Prescription NAD⁺ as an injection, drops or nasal spray at one flat price

  See Luvo Health →
• SLSystem Labs

  NAD⁺ bundled with glutathione, B-12 and sermorelin from one service

  See System Labs →